WO2004113394A3 - Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom - Google Patents

Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom Download PDF

Info

Publication number
WO2004113394A3
WO2004113394A3 PCT/GB2004/002608 GB2004002608W WO2004113394A3 WO 2004113394 A3 WO2004113394 A3 WO 2004113394A3 GB 2004002608 W GB2004002608 W GB 2004002608W WO 2004113394 A3 WO2004113394 A3 WO 2004113394A3
Authority
WO
WIPO (PCT)
Prior art keywords
comb polymer
polypeptides
reacting
functional group
polymerization initiator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2004/002608
Other languages
French (fr)
Other versions
WO2004113394A2 (en
Inventor
David Haddleton
Francois Lecolley
Lei Tao
Giuseppe Mantovani
Adrian Carmichael
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warwick Effect Polymers Ltd
Original Assignee
Warwick Effect Polymers Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP04742963A priority Critical patent/EP1646661B1/en
Priority to DK04742963T priority patent/DK1646661T3/en
Priority to AU2004249489A priority patent/AU2004249489A1/en
Priority to CA2530001A priority patent/CA2530001C/en
Priority to DE602004020347T priority patent/DE602004020347D1/en
Priority to JP2006516436A priority patent/JP5264073B2/en
Application filed by Warwick Effect Polymers Ltd filed Critical Warwick Effect Polymers Ltd
Publication of WO2004113394A2 publication Critical patent/WO2004113394A2/en
Publication of WO2004113394A3 publication Critical patent/WO2004113394A3/en
Anticipated expiration legal-status Critical
Priority to US11/498,525 priority patent/US8436104B2/en
Priority to US13/857,513 priority patent/US9200104B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F299/00—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers
    • C08F299/02—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates
    • C08F299/022—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates from polycondensates with side or terminal unsaturations
    • C08F299/024—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates from polycondensates with side or terminal unsaturations the unsaturation being in acrylic or methacrylic groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/448—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
    • C07D207/452—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
    • C08F290/02—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
    • C08F290/06—Polymers provided for in subclass C08G
    • C08F290/062—Polyethers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
    • C08F293/005—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F299/00—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers
    • C08F299/02—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates
    • C08F299/022—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates from polycondensates with side or terminal unsaturations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F4/00—Polymerisation catalysts
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2438/00—Living radical polymerisation
    • C08F2438/01—Atom Transfer Radical Polymerization [ATRP] or reverse ATRP

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Materials Engineering (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Polyethers (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Polymerization Catalysts (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

The application provides a method of producing a comb polymer comprising the steps of: (a) Providing: (i) a plurality of monomers which are linear, branched or star-shaped, substituted or non-substituted, and have an olefinically unsaturated moiety, the olefinically unsaturated moiety being capable of undergoing addition polymerisation; (ii) an initiator compound; the initiator compound comprising a homolytically cleavable bond. (iii) a catalyst capable of catalysing the polymerisation of the monomer; and (b) Causing the catalyst to catalyse, in combination with the initiator, the polymerisation of a plurality of the monomers to produce the comb polymer Catalysts and polymers obtainable by the process are also provided. Preferably, the comb polymer is capable of binding proteins and may be produced from monomers which are alkoxy polyethers, such as poly(alkyleneglycol) or polytetrahydrofuran.
PCT/GB2004/002608 2003-06-20 2004-06-18 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom Ceased WO2004113394A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DK04742963T DK1646661T3 (en) 2003-06-20 2004-06-18 Live radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, campolymer obtained thereby, polypeptide conjugates and drug obtained therefrom
AU2004249489A AU2004249489A1 (en) 2003-06-20 2004-06-18 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom
CA2530001A CA2530001C (en) 2003-06-20 2004-06-18 Polymer
DE602004020347T DE602004020347D1 (en) 2003-06-20 2004-06-18 INITIATOR FOR THE LIVING RADICAL POLYMERIZATION WITH A POLYPEPTIDES OR THE ABOLISHED FUNCTIONAL GROUP RESPONSE, CAMPOLYMER, POLYPETIDE CONJUGATES, AND ARRAY OBTAINED THEREWITH
JP2006516436A JP5264073B2 (en) 2003-06-20 2004-06-18 Living radical polymerization initiator containing a functional group capable of reacting with a polypeptide, etc., comb polymer obtained by using the same, polypeptide complex and drug obtained therefrom
EP04742963A EP1646661B1 (en) 2003-06-20 2004-06-18 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drung obtained therefrom
US11/498,525 US8436104B2 (en) 2003-06-20 2006-08-03 Polymer
US13/857,513 US9200104B2 (en) 2003-06-20 2013-04-05 Polymer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0314472.2A GB0314472D0 (en) 2003-06-20 2003-06-20 Polymer
GB0314472.2 2003-06-20

Related Child Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2004/002894 Continuation-In-Part WO2006003352A1 (en) 2003-06-20 2004-07-06 Living radical polymerization initiator comprising a functional group capable of reacting with polyeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom

Publications (2)

Publication Number Publication Date
WO2004113394A2 WO2004113394A2 (en) 2004-12-29
WO2004113394A3 true WO2004113394A3 (en) 2005-05-06

Family

ID=27637062

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2004/002608 Ceased WO2004113394A2 (en) 2003-06-20 2004-06-18 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom

Country Status (12)

Country Link
US (2) US8436104B2 (en)
EP (2) EP2161291A2 (en)
JP (1) JP5264073B2 (en)
AT (1) ATE427322T1 (en)
AU (1) AU2004249489A1 (en)
CA (1) CA2530001C (en)
DE (1) DE602004020347D1 (en)
DK (1) DK1646661T3 (en)
ES (1) ES2324994T3 (en)
GB (1) GB0314472D0 (en)
WO (1) WO2004113394A2 (en)
ZA (1) ZA200600590B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11590235B2 (en) 2013-09-08 2023-02-28 Kodiak Sciences Inc. Factor VIII zwitterionic polymer conjugates

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0301014D0 (en) * 2003-01-16 2003-02-19 Biocompatibles Ltd Conjugation reactions
GB0314472D0 (en) 2003-06-20 2003-07-23 Warwick Effect Polymers Ltd Polymer
JP5017107B2 (en) * 2004-07-06 2012-09-05 ワーウィック イフェクト ポリマーズ リミテッド Living radical polymerization initiator containing a functional group capable of reacting with a polypeptide, etc., comb polymer obtained by using the same, polypeptide complex and drug obtained therefrom
WO2007031734A1 (en) * 2005-09-14 2007-03-22 Ucb Pharma S.A. Comb polymers
SI1988910T1 (en) 2006-02-28 2018-02-28 Kodiak Sciences Inc. Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
CN100406479C (en) * 2006-05-25 2008-07-30 中国科学院长春应用化学研究所 β-diketone monoimine vanadium olefin polymerization catalyst containing trifluoromethyl group, preparation method and application
CA2655933C (en) 2006-06-23 2014-09-09 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
ITRM20060682A1 (en) * 2006-12-19 2008-06-20 Sicit Chemitech S P A NEW BIODEGRADABLE POLYMER DERIVATIVES
JP5340956B2 (en) * 2006-12-20 2013-11-13 アーケマ・インコーポレイテッド Encapsulation and / or binding of polymers
EP2118150B1 (en) 2007-02-14 2015-09-23 Biocompatibles UK Limited Derivatisation of biological molecules
JP5798320B2 (en) 2007-09-24 2015-10-21 ノクソン・ファルマ・アクチエンゲゼルシャフト Nucleic acids that bind to C5a
WO2009053700A1 (en) * 2007-10-23 2009-04-30 Cancer Research Technology Limited Modification of nucleic acid-containing biological entities
WO2009112301A2 (en) * 2008-03-10 2009-09-17 Basf Se Polypeptide agents in the form of conjugates of keratin-binding polypeptides, polymers, and effector molecules, method for the production thereof, and use thereof
CN104829714A (en) 2008-11-03 2015-08-12 阿莱斯亚生物疗法股份有限公司 Antibodies that specifically block the biological activity of a tumor antigen
WO2010108657A2 (en) 2009-03-23 2010-09-30 Noxxon Pharma Ag C5a binding nucleic acids and the use thereof
US8067201B2 (en) 2009-04-17 2011-11-29 Bristol-Myers Squibb Company Methods for protein refolding
GB0912160D0 (en) 2009-07-13 2009-08-26 Warwick Effect Polymers Ltd Polymer modified macromolecules
CA2781637A1 (en) * 2009-11-27 2011-06-03 Basf Se Dendritic polyurea for solubilizing active substances of low solubility
WO2011075185A1 (en) 2009-12-18 2011-06-23 Oligasis Targeted drug phosphorylcholine polymer conjugates
US8871920B2 (en) 2010-04-21 2014-10-28 Noxxon Pharma Ag Lipid binding nucleic acids
WO2012025251A1 (en) 2010-08-27 2012-03-01 Noxxon Pharma Ag Nucleic acids for treatment of chronic complications of diabetes
SG188220A1 (en) 2010-09-09 2013-04-30 Noxxon Pharma Ag Sdf-1 binding nucleic acids and the use thereof in cancer treatment
WO2012055573A1 (en) 2010-10-29 2012-05-03 Noxxon Pharma Ag Use of hepcidin binding nucleic acids for depletion of hepcidin from the body
WO2012095303A1 (en) 2011-01-10 2012-07-19 Noxxon Pharma Ag Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same
CA2893376A1 (en) 2011-03-31 2012-10-04 Alethia Biotherapeutics Inc. Antibodies against kidney associated antigen 1 and antigen binding fragemnts thereof
SG11201401362TA (en) 2011-10-21 2014-05-29 Noxxon Pharma Ag Glucagon binding nucleic acids
AU2013209234B2 (en) 2012-01-09 2017-11-09 Adc Therapeutics Sa Method for treating breast cancer
PT2802660T (en) 2012-01-10 2020-04-21 Aptarion Biotech Ag New c5a binding nucleic acids
EP2802659A1 (en) 2012-01-10 2014-11-19 Noxxon Pharma AG Nucleic acids specifically binding cgrp
EP3065744B1 (en) 2013-11-04 2021-04-21 Noxxon Pharma AG A ccl2 antagonist for use in treating proteinuria
WO2015200905A2 (en) 2014-06-28 2015-12-30 Oligasis, Llc Dual pdgf/vegf antagonists
EP3207128B1 (en) 2014-10-17 2022-07-27 Kodiak Sciences Inc. Butyrylcholinesterase zwitterionic polymer conjugates
US10098960B2 (en) 2015-04-03 2018-10-16 Ucl Business Plc Polymer conjugate
IL290457B2 (en) 2015-12-30 2025-02-01 Kodiak Sciences Inc Antibodies and conjugates thereof
WO2017178119A1 (en) 2016-04-15 2017-10-19 Noxxon Pharma Ag Method of modulating the number and the distribution of tumor-infiltrating leukocytes in tumors
CN117534764A (en) 2016-06-06 2024-02-09 阿布泽纳(英国)有限公司 Antibodies, uses thereof and conjugates thereof
GB201614162D0 (en) 2016-08-18 2016-10-05 Polytherics Ltd Antibodies, uses thereof and conjugates thereof
CA3092588A1 (en) 2018-03-02 2019-09-06 Kodiak Sciences Inc. Il-6 antibodies and fusion constructs and conjugates thereof
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
CN114520325B (en) * 2022-01-07 2023-07-04 惠州锂威新能源科技有限公司 Preparation method of nitrogen-doped carbon material, product, negative electrode plate and secondary battery
AU2023287476A1 (en) 2022-06-21 2024-12-05 TME Pharma AG Methods for treating a tumor in a subject
EP4306640A1 (en) 2022-06-21 2024-01-17 TME Pharma AG Method for treating a tumor in a subject
CN119585294A (en) * 2022-07-25 2025-03-07 南京金斯瑞生物科技有限公司 A method for site-specific synthesis of protein-active molecule conjugates
WO2024026148A1 (en) * 2022-07-29 2024-02-01 University Of Virginia Patent Foundation Compositions comprising linear, star-shaped, and comb-like stapled p9-peg conjugates and methods of use thereof
WO2025196240A1 (en) 2024-03-20 2025-09-25 Aptarion Biotech Ag Method of treating a disorder with a c5a inhibitor
EP4620474A1 (en) 2024-03-20 2025-09-24 APTARION biotech AG Method of treating a disorder with a c5a inhibitor
CN119661602B (en) * 2024-12-13 2025-10-10 湖南省中医药研究院 A small molecule monomer containing azophenyl and ferrocenyl groups, and its synthesis method and use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997047661A1 (en) * 1996-06-12 1997-12-18 University Of Warwick Polymerisation catalyst and process
WO2003062290A1 (en) * 2002-01-16 2003-07-31 Biocompatibles Uk Limited Polymer conjugates
WO2004063237A1 (en) * 2003-01-16 2004-07-29 Biocompatibles Uk Limited Conjugation reactions

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE300519T1 (en) * 1989-04-19 2005-08-15 Enzon Inc METHOD FOR PRODUCING MODIFIED POLYPEPTIDES CONTAINING A POLYPEPTIDE AND A POLYALKYLENE OXIDE
US5763548A (en) 1995-03-31 1998-06-09 Carnegie-Mellon University (Co)polymers and a novel polymerization process based on atom (or group) transfer radical polymerization
EP0837889B1 (en) 1995-06-26 2002-04-24 Basf Aktiengesellschaft New polymer composition for graft copolymers as well as mixtures thereof and thermoplastic compounds containing them
US5807937A (en) * 1995-11-15 1998-09-15 Carnegie Mellon University Processes based on atom (or group) transfer radical polymerization and novel (co) polymers having useful structures and properties
WO1998001478A1 (en) 1996-07-10 1998-01-15 E.I. Du Pont De Nemours And Company Polymerization with living characteristics
US6214966B1 (en) * 1996-09-26 2001-04-10 Shearwater Corporation Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
TW593347B (en) * 1997-03-11 2004-06-21 Univ Carnegie Mellon Improvements in atom or group transfer radical polymerization
FR2764892B1 (en) 1997-06-23 2000-03-03 Rhodia Chimie Sa PROCESS FOR THE SYNTHESIS OF BLOCK POLYMERS
US20050158273A1 (en) * 1997-09-25 2005-07-21 Harris J. M. Soluble, degradable polyethylene glycol) derivatives for controllable release of bound molecules into solution
GB9725455D0 (en) 1997-12-02 1998-01-28 Univ Warwick Supported polymerisation catalyst
BR9815179A (en) 1997-12-18 2000-10-10 Du Pont Process for producing a polymer, polymer, coating composition and chain transfer agent.
AR019322A1 (en) * 1998-06-18 2002-02-13 Smithkline Beecham Corp SULFONYL DERIVATIVES REPLACED BY HETEROCICLO-ETANODIONANILINA REPLACED BY HETEROCICLO, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE FOR LAMANUFACTURE OF A MEDICINAL PRODUCT
JP4231548B2 (en) * 1998-12-28 2009-03-04 日東電工株式会社 Pressure-sensitive adhesive composition and method for producing the same
TWI291472B (en) * 1999-03-23 2007-12-21 Univ Carnegie Mellon Catalytic processes for the controlled polymerization of free radically (co)polymerizable monomers and functional polymeric systems prepared thereby
GB0014225D0 (en) * 2000-06-09 2000-08-02 Univ Warwick Polymerisation initiator and use
KR100396983B1 (en) 2000-07-29 2003-09-02 이강춘 Highly reactive branched polymer and proteins or peptides conjugated with the polymer
TW593427B (en) 2000-12-18 2004-06-21 Nektar Therapeutics Al Corp Synthesis of high molecular weight non-peptidic polymer derivatives
US7056500B2 (en) 2001-10-18 2006-06-06 Nektar Therapeutics Al, Corporation Polymer conjugates of opioid antagonists
EP1446438A2 (en) 2001-11-07 2004-08-18 Nektar Therapeutics Al, Corporation Branched polymers and their conjugates
US20030171285A1 (en) 2001-11-20 2003-09-11 Finn Rory F. Chemically-modified human growth hormone conjugates
US7144978B2 (en) * 2002-01-15 2006-12-05 Pan Asia Bio Co., Ltd. Multidrop tree branching functional polyethylene glycol, methods of preparing and using same
DE10228103A1 (en) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungicidal active ingredient combinations
JP4764630B2 (en) 2002-09-09 2011-09-07 ネクター セラピューティックス Water-soluble polymer alkanal
US6992217B2 (en) * 2002-12-11 2006-01-31 3M Innovative Properties Company Ring-opened azlactone initiators for atom transfer radical polymerization
GB0314472D0 (en) 2003-06-20 2003-07-23 Warwick Effect Polymers Ltd Polymer
US7563748B2 (en) 2003-06-23 2009-07-21 Cognis Ip Management Gmbh Alcohol alkoxylate carriers for pesticide active ingredients
PL1656410T3 (en) 2003-07-22 2010-08-31 Nektar Therapeutics Method for preparing functionalized polymers from polymer alcohols

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997047661A1 (en) * 1996-06-12 1997-12-18 University Of Warwick Polymerisation catalyst and process
WO2003062290A1 (en) * 2002-01-16 2003-07-31 Biocompatibles Uk Limited Polymer conjugates
WO2004063237A1 (en) * 2003-01-16 2004-07-29 Biocompatibles Uk Limited Conjugation reactions

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HADDLETON, DAVID M. ET AL: "Phenolic ester-based initiators for transition metal mediated living polymerization", MACROMOLECULES , 32(26), 8732-8739 CODEN: MAMOBX; ISSN: 0024-9297, 1999, XP002314659 *
HADDLETON, PERRIER, BON: "Copper (I).mediated living radical polymerization in the presence pf oxyethylene groups: online 1H NMR spectroscopy to investigate solvents effects", MACROMOLECULES, vol. 33, 10 November 2000 (2000-11-10), pages 8246 - 8251, XP002295368 *
NARAIN, RAVIN ET AL: "Direct Synthesis and Aqueous Solution Properties of Well-Defined Cyclic Sugar Methacrylate Polymers", MACROMOLECULES , 36(13), 4675-4678 CODEN: MAMOBX; ISSN: 0024-9297, 31 May 2003 (2003-05-31), XP002314660 *
WANG X-S ET AL: "FACILE SYNTHESIS OF ACIDIC COPOLYMERS VIA ATOM TRANSFER RADICAL POLYMERIZATION IN AQUEOUS MEDIA AT AMBIENT TEMPERATURE", MACROMOLECULES, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 33, no. 2, 25 January 2000 (2000-01-25), pages 255 - 257, XP000898356, ISSN: 0024-9297 *
WANG, ARMES: "Facile atom transfer radical polymerization of methoxy capped oligo(ethylene glycol) methacrylate in aqueous media at ambiant temperature", MACROMOLECULES, vol. 33, 2000, pages 6640 - 6647, XP002315896 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11590235B2 (en) 2013-09-08 2023-02-28 Kodiak Sciences Inc. Factor VIII zwitterionic polymer conjugates

Also Published As

Publication number Publication date
EP2161291A2 (en) 2010-03-10
US8436104B2 (en) 2013-05-07
JP2007516302A (en) 2007-06-21
DK1646661T3 (en) 2009-07-20
US9200104B2 (en) 2015-12-01
US20130295040A1 (en) 2013-11-07
JP5264073B2 (en) 2013-08-14
AU2004249489A2 (en) 2004-12-29
ZA200600590B (en) 2007-07-25
AU2004249489A1 (en) 2004-12-29
CA2530001A1 (en) 2004-12-29
US20080300348A1 (en) 2008-12-04
EP1646661B1 (en) 2009-04-01
DE602004020347D1 (en) 2009-05-14
CA2530001C (en) 2011-03-01
GB0314472D0 (en) 2003-07-23
EP1646661A2 (en) 2006-04-19
ATE427322T1 (en) 2009-04-15
ES2324994T3 (en) 2009-08-21
WO2004113394A2 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
ZA200600590B (en) Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides of the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom
Nuyken et al. Graft and block copolymers via polymeric azo initiators
Simon et al. Hyperbranched methacrylates by self‐condensing group transfer polymerization
US8685417B2 (en) Polymer encapsulation and/or binding
Chen et al. ABA and Star Amphiphilic Block Copolymers Composed of Polymethacrylate Bearing a Galactose Fragment and Poly (ε‐caprolactone)
DE60019427D1 (en) METHOD FOR THE PRODUCTION OF CYCLOOLEFIN POLYMERS AND POLYMERIZABLE CYCLOOLEFINES
EP1767555A3 (en) Novel polymer and cement admixture using the same
KR20010015856A (en) Heterofunctionalized star-shaped poly(ethylene glycols) for protein modification
KR890003888A (en) Thermoplastic Molding Material
Chen et al. Synthesis of poly (styryl sugar) s by TEMPO mediated free radical polymerization
CN114456363A (en) Catalytic system and synthesis method of multi-block copolymer
Shi et al. Ultra-fast RAFT polymerisation of poly (ethylene glycol) acrylate in aqueous media under mild visible light radiation at 25° C
CA2707131A1 (en) Cross-linkable vinylester-copolymers and use thereof as low-profile-additives
Abdellatif et al. Synthesis of polyesters containing long aliphatic methylene units by ADMET polymerization and synthesis of ABA-triblock copolymers by one-pot end modification and subsequent living ring-opening polymerization
CA1336728C (en) Preparation process of block copolymers and resulting block copolymers
EP1000954A4 (en) Polymers and process for producing polymers
ES2118102T3 (en) PROCEDURE FOR PREPARING POLYMERS AND MOLDING COMPOSITIONS BASED ON THEM.
EP1085027A4 (en) Polymer and process for producing polymer
EP1688440A4 (en) Novel hyperbranched polymer
WO2005054488A3 (en) Process for producing polymers
KR890003807A (en) Process for producing molded articles of metathesis polymerized polymer
Takimoto et al. Controlling the block sequence of multi-block oligomer ligands for neutralization of a target peptide
Kim et al. Polymerization of methyl methacrylate with nickel α-diimine catalysts: effect of the methyl position in the ligand
Kikuchi et al. Preparation of styryl-ended rod-like poly (n-hexyl isocyanate) macromonomers and their radical co-polymerization behavior with styrene
KR100569880B1 (en) Biodegradable aliphatic polyester in which polyethylene glycol having a functional group is grafted in its structure, and a method of manufacturing the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004249489

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2530001

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2006516436

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2004249489

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004742963

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006/00590

Country of ref document: ZA

Ref document number: 169/KOLNP/2006

Country of ref document: IN

Ref document number: 200600590

Country of ref document: ZA

WWP Wipo information: published in national office

Ref document number: 2004742963

Country of ref document: EP